Autoimmune diseases (AID) are increasingly prevalent conditions which comprise more
than 100 distinct clinical entities that are responsible for a great disease burden worldwide …

Autoantibodies represent a hallmark of rheumatoid arthritis (RA), with the rheumatoid factor
(RF) and antibodies against citrullinated proteins (ACPA) being the most acknowledged …

Objective To develop evidence-based European Alliance of Associations for Rheumatology
(EULAR) points to consider (PtCs) for the management of difficult-to-treat rheumatoid …

Elderly-onset rheumatoid arthritis (EORA) is prevalent among older patients, and its
incidence is increasing due to aging societies. However, differentiating between EORA and …

Rheumatoid arthritis (RA) is the most common systemic autoimmune disease and also the
most severe arthritic disorder. The measurement of rheumatoid factor (RF) and anti …

Increased research over the past 30 years has greatly improved the understanding of the
pathophysiological mechanisms and clinical aspects of autoantibody-positive rheumatoid …

Ревматоидный артрит (РА)-наиболее частое иммуновоспалительное (аутоиммунное)
ревматическое заболевание (ИВРЗ), проявляющийся хроническим эрозивным …

Rheumatoid arthritis (RA) is a highly prevalent autoimmune disease and the most common
form of autoimmune inflammatory arthritis. Studies of RA pathogenesis have contributed …

In the last decades, the concept of preclinical rheumatoid arthritis (RA) has become
established. In fact, the discovery that disease mechanisms start years before the onset of …

Objectives To summarise the evidence on diagnostic issues in difficult-to-treat rheumatoid
arthritis (D2T RA) informing the EULAR recommendations for the management of D2T RA …